Today, the Hong Kong stock market rose moderately, with Heng Science flipping green in the last trading session. The ASCO conference is about to open, coupled with the accelerating overseas expansion of domestic innovative drugs, causing fluctuations and rebounds in the innovative drug ETF; the chip industry chain fell back, and the Science and Technology 50 ETF collectively plummeted. As of the close, the Hang Seng Index rose by 0.7% to 25182.39 points, with a total daily turnover of 462.07 billion Hong Kong dollars; the Hang Seng Technology Index fell by 0.09% to 4884.23 points. In the Hong Kong stock-related ETFs, the products with the highest turnover had varied performances: Yingfu Fund (02800) rose by 0.55% to 25.4 Hong Kong dollars; Southern Double Long Haier (07709) rose by 3.07% to 137.65 Hong Kong dollars; Hang Seng China Enterprises (02828) rose by 0.68% to 86.38 Hong Kong dollars. Industry Performance 1. The innovative drug sector fluctuated and rebounded, leading the Hong Kong stock market, with all related ETFs rising. By the close, the Hang Seng Innovation Drug ETF China Industrial Bank (159217) rose by 5.22% to 1.129 yuan; the Hang Seng Innovation Drug ETF Huatai Bairui (520500) rose by 4.70% to 1.381 yuan; the Hang Seng Innovation Drug ETF Huatai Bairui (520500) rose by 4.66% to 1.37 yuan. With the ASCO conference about to open, coupled with the hundred-billion-dollar level BD cooperation between Daiichi Biological (01801) and Pfizer, the sector sentiment was significantly boosted. 2. The Science and Technology 50 ETF collectively plummeted, and the chip industry chain was sold off. By the close, the Science and Technology 50 Index fell by over 5%, Boshi Science and Technology 50 (02832) fell by 5.29% to 12.71 Hong Kong dollars, PP Science and Technology 50...